Company Filing History:
Years Active: 1995
Title: Wolfgang Gebhard: Innovator in Proteinase Inhibitors
Introduction
Wolfgang Gebhard is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of proteinase inhibitors. His work has implications for pharmaceutical compositions, showcasing the intersection of innovation and healthcare.
Latest Patents
Wolfgang Gebhard holds a patent for "Human Bikunin variants as proteinase inhibitors, and medicaments." This patent describes a proteinase inhibitor that consists of the amino acid sequence 21 to 147 of human bikunin, with at least one amino acid residue replaced by another naturally occurring amino acid. This innovative approach enhances the utility of proteinase inhibitors in medical applications.
Career Highlights
Gebhard is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His role at Bayer has allowed him to work on cutting-edge research and development projects that aim to improve health outcomes through innovative solutions.
Collaborations
Wolfgang Gebhard has collaborated with notable colleagues such as Hans Fritz and Rathindra Das. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of biochemistry.
Conclusion
Wolfgang Gebhard's contributions to the development of proteinase inhibitors highlight his innovative spirit and dedication to advancing medical science. His work continues to influence the pharmaceutical industry and improve therapeutic options for patients.